Literature DB >> 17208142

Surgical benchmarks for the treatment of invasive bladder cancer.

Eila C Skinner1, John P Stein, Donald G Skinner.   

Abstract

Radical cystectomy is the gold standard for treatment of localized invasive bladder cancer in the United States. In recent years, there has been increasing focus on the importance of surgical technique as a factor that may influence the clinical and oncologic outcome of the operation, beyond the classically recognized patient and tumor-related factors. There is still insufficient high-quality evidence to support the absolute standardization of the surgical technique or the establishment of firm benchmarks by which the individual surgeon can measure performance. However, there is considerable evidence suggesting that 3 aspects of surgical technique have an impact on outcome: (1) Positive surgical margins nearly always result in ultimate cancer death. The rate of positive margins varies with surgeon experience as well as with cancer-specific variables. (2) The extent of lymphadenectomy has a significant impact on recurrence rates of the cancer, regardless of whether the lymph nodes are pathologically positive or not. (3) Higher volume surgeons have lower operative mortality and fewer positive surgical margins than low-volume surgeons. Higher volume hospitals also have lower operative mortalities and shorter hospital stays for patients who have undergone radical cystectomy. In this review, the authors evaluate the evidence supporting each of these statements and suggest potential areas of standardization of surgical technique that could translate into improved patient outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17208142     DOI: 10.1016/j.urolonc.2006.05.010

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  18 in total

1.  Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial.

Authors:  Mohamed S Zaghloul; John P Christodouleas; Andrew Smith; Ahmed Abdallah; Hany William; Hussein M Khaled; Wei-Ting Hwang; Brian C Baumann
Journal:  JAMA Surg       Date:  2018-01-17       Impact factor: 14.766

2.  Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder.

Authors:  Vladimir Novotny; Michael Froehner; Matthias May; Chris Protzel; Katrin Hergenröther; Michael Rink; Felix K Chun; Margit Fisch; Florian Roghmann; Rein-Jüri Palisaar; Joachim Noldus; Michael Gierth; Hans-Martin Fritsche; Maximilian Burger; Danijel Sikic; Bastian Keck; Bernd Wullich; Philipp Nuhn; Alexander Buchner; Christian G Stief; Stefan Vallo; Georg Bartsch; Axel Haferkamp; Patrick J Bastian; Oliver W Hakenberg; Stefan Propping; Atiqullah Aziz
Journal:  World J Urol       Date:  2015-02-08       Impact factor: 4.226

3.  Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database.

Authors:  Mahir Maruf; Abhinav Sidana; Stephanie Purnell; Amit L Jain; Sam J Brancato; Piyush K Agarwal
Journal:  Int Urol Nephrol       Date:  2017-12-23       Impact factor: 2.370

4.  Racial variation in the quality of surgical care for bladder cancer.

Authors:  Daniel A Barocas; Joann Alvarez; Tatsuki Koyama; Christopher B Anderson; Darryl T Gray; Jay H Fowke; Chaochen You; Sam S Chang; Michael S Cookson; Joseph A Smith; David F Penson
Journal:  Cancer       Date:  2013-12-11       Impact factor: 6.860

5.  Outcome of treatment of bladder cancer: a comparison between low-volume hospitals and an oncology centre.

Authors:  R R de Vries; O Visser; J A Nieuwenhuijzen; S Horenblas
Journal:  World J Urol       Date:  2010-02-04       Impact factor: 4.226

6.  Characterizing the Morbidity of Postchemotherapy Retroperitoneal Lymph Node Dissection for Testis Cancer in a National Cohort of Privately Insured Patients.

Authors:  Liam C Macleod; Saneal Rajanahally; Jasmir G Nayak; Brodie A Parent; Jorge D Ramos; George R Schade; Sarah K Holt; Atreya Dash; John L Gore; Daniel W Lin
Journal:  Urology       Date:  2016-01-21       Impact factor: 2.649

7.  The impact of positive soft tissue surgical margins following radical cystectomy for high-grade, invasive bladder cancer.

Authors:  Pantelis Hadjizacharia; John P Stein; Jie Cai; Gus Miranda
Journal:  World J Urol       Date:  2008-11-20       Impact factor: 4.226

Review 8.  The role of lymph node density in bladder cancer prognostication.

Authors:  Marcus L Quek; Robert C Flanigan
Journal:  World J Urol       Date:  2008-11-20       Impact factor: 4.226

Review 9.  Open radical cystectomy: still the gold standard for muscle invasive bladder cancer.

Authors:  Bernhard Kiss; Fiona C Burkhard; George N Thalmann
Journal:  World J Urol       Date:  2015-11-19       Impact factor: 4.226

10.  Modified ileal conduit intracorporeally accomplished following laparoscopic radical cystectomy with enhanced recovery protocols: experience with 48 cases.

Authors:  Houyi Wei; Mingshuai Wang; Wahafu Wasilijiang; Wei Wang; Xing Guan; Xiaoguang Zhou; Liming Song; Nianzeng Xing; Yinong Niu
Journal:  Transl Androl Urol       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.